piribedil has been researched along with Mood Disorders in 2 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixty patients with different types of Parkinson's disease (PD), the disease stage 2." | 2.71 | [An impact of pronoran on cognitive and affective disorders in Parkinson's disease]. ( Golubev, VL; Pilipovich, AA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pilipovich, AA | 1 |
| Golubev, VL | 1 |
| Post, RM | 1 |
| Jimerson, DC | 1 |
| Bunney, WE | 1 |
1 review available for piribedil and Mood Disorders
| Article | Year |
|---|---|
Perspectives in the treatment of the psychoneurological disorders: affective disorders.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Mood Disorders; Peptide Frag | 1979 |
1 trial available for piribedil and Mood Disorders
| Article | Year |
|---|---|
[An impact of pronoran on cognitive and affective disorders in Parkinson's disease].
Topics: Adult; Affect; Aged; Antiparkinson Agents; Cognition; Cognition Disorders; Female; Humans; Male; Mid | 2005 |